Sign in Create account

Thyrocare Technologies Limited

Healthcare · Healthcare Services

NSE: THYROCARE BSE: 539871
₹534.15
▼ -12.95 (-2.37%)
Sept. 30, 2026 · NSE · nse_bhavcopy
Quality
87/100
Strong
Valuation
2/100
Expensive
Momentum
29/100
Bearish

QVM read Quality, pricey and fading Quality Strong, Valuation Expensive, Momentum Bearish

Tradinity's own scoring, not a copy of any third party's -- see the Key Metrics section for the real ratios behind each number.

Key Metrics

Market Capitalization
₹8,502 Cr
PE (TTM)
34.1
Industry median 50.2 (44 companies)
Price to Book
14.5
PEG (TTM)
-1.6
Institutions holding %
26.36%
FII + DII, latest filed period
Piotroski Score
7
Relative return vs Nifty50, qtr %
3.2
Relative return vs Sector, qtr %
1.1
Free Cash Flow
₹192 Cr
as of March 31, 2026
Industry median ₹1 Cr (75 companies)
EPS Growth (YoY)
-53.68%
as of June 30, 2026
Industry median 13.27% (57 companies)
Net Profit Growth (TTM)
52.54%
as of June 30, 2026
Industry median 7.21% (57 companies)
Operating Revenue Growth (TTM)
22.84%
as of June 30, 2026
Industry median 12.82% (57 companies)
Profit Growth (YoY)
39.17%
as of June 30, 2026
Industry median 8.53% (57 companies)
Revenue Growth (YoY)
26.14%
as of June 30, 2026
Industry median 18.84% (52 companies)
Current Ratio
3.39
as of March 31, 2026
Industry median 2.06 (74 companies)
Debt to Equity
0.00
as of March 31, 2026
Industry median 0.11 (62 companies)
Interest Coverage
61.14
as of June 30, 2026
Industry median 7.94 (57 companies)
Net Margin
22.23%
as of June 30, 2026
Industry median 9.88% (61 companies)
Operating Margin (EBIT)
30.09%
as of June 30, 2026
Industry median 17.21% (61 companies)
Operating Margin (TTM)
28.00%
as of June 30, 2026
Industry median 16.20% (59 companies)
Return on Assets
21.79%
as of March 31, 2026
Industry median 5.40% (58 companies)
Return on Capital Employed
33.62%
as of March 31, 2026
Industry median 10.44% (56 companies)
Return on Equity
27.79%
as of March 31, 2026
Industry median 10.16% (58 companies)

Investment checklist

Tradinity's own yes/no questions with the rule stated beside each. “Items without enough data are left out, never counted as a No, and the totals count only answered questions. A summary of numbers on this page, not advice.

Financials

8 of 8 met
  • Yes Net profit is higher than a year earlier in each of the last 4 quarters
  • Yes Revenue is higher than a year earlier in each of the last 4 quarters
  • Yes Quality score is Strong (70 or more)
  • Yes Piotroski F-score is 7 or more (score 7)
  • Yes Debt to equity is below 0.5 (0.00)
  • Yes Return on equity is 15% or more (27.8%)
  • Yes Net cash flow for the latest year is positive
  • Yes Cash from operations is higher than the year before

Ownership

3 of 4 met
  • Yes FII/FPI or DII holding rose in the latest quarter
  • Yes Promoter holding rose or was unchanged in the latest quarter
  • No Promoter pledge is 5% of their holding or less and not rising (100.0% pledged)
  • Yes Insiders have not sold in the past 3 months (no open-market sale filed in the last 3 months)

Peer comparison

2 of 3 met
  • No 1-year return beats the industry median
  • Yes Revenue growth beats the industry median
  • Yes Profit growth beats the industry median

Value and momentum

0 of 6 met
  • No Price sits in the Buy zone of its own historical PE range (Fair Value Zone)
  • No Valuation score is Undervalued (70 or more)
  • No Momentum score is Bullish (70 or more)
  • No Price is above the 5, 10 and 20 day averages
  • No Price is above the 50, 100 and 200 day averages
  • No Latest candle has a bullish shape (hammer, dragonfly doji, white marubozu)

Price

Download CSV

PE/EPS use each quarter's real filed EPS only from 45 days after quarter-end (no look-ahead) against the raw close of the day. Price-to-book isn't a mode here: the feed has no dated share count, so there's no real history to chart.

RSI (14) (same adjusted close series as the price chart above)

MACD (12, 26, 9) (same adjusted close series as the price chart above)

Relative Returns (vs NIFTY 50)

Prices adjusted for splits and bonuses. * = a corporate action affecting this date could not be parsed and is not reflected.

Price range

Day return
-2.4%
Low 532.7000 · High 550.6000
1W return
-6.9%
Low 532.7000 · High 576.7500
1M return
-11.6%
Low 532.7000 · High 613.0000
52W return
-53.5%
Low 342.5500 · High 1610.0000
Lifetime High ₹1591.9000 (Nov. 18, 2025)
Lifetime Low ₹349.5500 (March 30, 2026)

Full price history and technicals →

Technicals

Full technicals, indicators & Volume/Delivery →

EMA & SMA

Bullish1
Bearish5
5D
549.0
10D
555.5
20D
562.7
50D
564.8
100D
542.9
200D
481.8

Delivery and volume

Day avg. delivery
46.5%
Week avg. delivery
58.8%
Month avg. delivery
57.7%

Week = 5 sessions, Month = 22 sessions ending the latest trading day — the same combined NSE+BSE delivery data as the table below, just summed.

Resistance and support

539.15
Pivot
First resistance545.60
Second resistance557.05
Third resistance563.50
First support527.70
Second support521.25
Third support509.80
Day RSI36.3
Day MFI33.3
Day MACD-8.14
Day MACD signal-6.15

Beta

1M1.14
3M0.46
1Y0.54
3Y0.47

Price change analysis

↓ -11.6%
Over 1 Month
LowHigh
532.70613.00
↓ -1.7%
Over 3 Months
LowHigh
505.50662.00
↑ 47.6%
Over 6 Months
LowHigh
352.90662.00
↓ -53.5%
Over 1 Year
LowHigh
342.551610.00
Legend Positive indicator Neutral indicator Negative indicator

Buy/Sell Zone

View Buy/Sell Zone →
Current PE 34.1 (own history: 18.1–52.1)
Fair Value Zone

Financials

View full financials, peers & valuation multiples →
Revenue (June 30, 2026)
₹226 Cr
Net profit (June 30, 2026)
₹50 Cr
Basic EPS (June 30, 2026)
₹3.1500

Ranks #18 of 62 in Healthcare Services by market cap -- full peer table on the Financials page.

Shareholding pattern / Ownership

Shareholding summary

Jun 2026
  • Promoter60.92%
  • Mutual funds19.86%
  • FII/FPI5.44%
  • Other DII1.06%
  • Public12.72%

Largest holders

NameCategoryShares %Shares
Docon Technologies Private LimitedPromoter60.9200%96969696
Nippon Life India Trustee Ltd-A/C Nippon India Small Cap FundPublic5.9900%9534712
Icici Prudential Pharma Healthcare And Diaganostics (P.H.D) FundPublic5.5700%8857893
Hsbc Mutual Fund - Hsbc Midcap FundPublic3.8400%6110670
Aditya Birla Sun Life Trustee Private Limited A/C - Aditya Birla Sun Life Elss Tax Saver FundPublic3.1500%5007086

As of June 30, 2026. Only holders the filing discloses individually.

Historical promoter holding

Promoters holdings were unchanged at 60.92% in Jun 2026 qtr

Historical fii holding

FII/FPI holdings increased from 5.37% to 5.44% in Jun 2026 qtr

Historical mutual fund holding

Mutual funds holdings increased from 19.45% to 19.86% in Jun 2026 qtr

18 mutual fund schemes also hold this stock.

All shareholding details →

Insider trading, SAST & pledges

All 105 insider trades, 47 SAST, 20 pledge events →

Latest insider trades

FiledPersonCategoryTypeQuantityValue
1 Apr 2026 Geetanjali Satish Shahane Other Buy 0 ₹0
1 Apr 2026 Priyanka Jagnani Jain Other Buy 0 ₹0
20 Mar 2026 Piyush Singh Other Buy 0 ₹0
20 Mar 2026 Brijesh Kumar Other Buy 0 ₹0
20 Mar 2026 Rahul Guha Other Buy 0 ₹0
19 Mar 2026 Gaurav Verma Other Buy 0 ₹0
17 Mar 2026 Rajdeep Panwar Other Buy 0 ₹0
17 Mar 2026 Gaurav Verma Other Buy 0 ₹0
11 Mar 2026 Jagpal Singh Dhanjal Other Buy 0 ₹0
9 Mar 2026 Mohammad Shadab Alam Other Sell 0 ₹0

All insider and SAST disclosures →

Deals (Bulk & Block)

All 65 deals, with filters and CSV →
DateClientDealActionQuantityPriceExchange
13 Aug 2026 WHITEOAK CAPITAL MUTUAL FUND Block Buy 641,000 624.0000 NSE
13 Aug 2026 TATA AIA LIFE INSURANCE COMPANY LIMITED Block Buy 481,000 624.0000 NSE
13 Aug 2026 MORGAN STANLEY ASIA SINGAPORE PTE Block Buy 444,846 624.0000 NSE
13 Aug 2026 MORGAN STANLEY ASIA SINGAPORE PTE Block Buy 456,000 624.0000 NSE
13 Aug 2026 KUWAIT INVESTMENT AUTHORITY Block Buy 401,000 624.0000 NSE
13 Aug 2026 KOTAK MAHINDRA LIFE INSURANCE COMPANY LIMITED Block Buy 2,400,000 624.0000 NSE
13 Aug 2026 ITI MUTUAL FUND Block Buy 401,000 624.0000 NSE
13 Aug 2026 ICICI PRUDENTIAL MUTUAL FUND Block Buy 801,000 624.0000 NSE
13 Aug 2026 HSBC MUTUAL FUND Block Buy 2,999,731 624.0000 NSE
13 Aug 2026 HBM HEALTHCARE INVESTMENTS (CAYMAN) LTD Block Buy 761,000 624.0000 NSE

All bulk and block deals →

Dividends

Full dividend history →
Last 12 months ₹14.00 per share
Dividend yield 2.62%
Ex-dateSubjectPer share (₹)Record date
23 Jun 2026 Dividend - Rs 7 Per Share 7.0000 23 Jun 2026
24 Oct 2025 Interim Dividend - Rs 7 Per Share 7.0000 24 Oct 2025
25 Jul 2025 Dividend - Rs 21 Per Share 21.0000 25 Jul 2025
16 Aug 2024 Dividend - Rs 18 Per Share 18.0000 16 Aug 2024
20 Apr 2023 Interim Dividend - Rs 18 Per Share 18.0000 20 Apr 2023
11 May 2022 Interim Dividend - Rs 15 Per Share 15.0000 12 May 2022
17 Jun 2021 Annual General Meeting/Dividend - Rs 15 Per Share 15.0000 —
12 Nov 2020 Interim Dividend - Rs 10 Per Share 10.0000 13 Nov 2020
21 Nov 2019 Interim Dividend - Rs 5 Per Share 5.0000 22 Nov 2019
14 Aug 2019 Dividend - Rs 20 Per Share 20.0000 —

Corporate Actions

Full history (17 events) →

Bonuses, splits, buybacks and other events. Dividends are listed separately above.

Ex-dateTypeSubject
28 Nov 2025BONUSBonus 2:1
25 Jul 2022OTHERAnnual General Meeting

All corporate actions →

Board Meetings

View board meeting history →

Quarterly results, AGMs, buybacks and other board-approved business.

DatePurposeResults
23 Jul 2026 Financial Results Yes
7 May 2026 Financial Results/Dividend Yes
28 Jan 2026 Financial Results Yes
14 Oct 2025 Financial Results/Dividend/Bonus Yes
23 Jul 2025 Financial Results Yes

Corporate Announcements

All 795 announcements, with search →

Exchange disclosures (NSE and BSE), most recent first.

DateCategoryAnnouncement
29 Sep 2026 Copy of Newspaper Publication Thyrocare Technologies Limited has informed the Exchange about Copy of Newspaper Publication for Notice of Postal Ballot
29 Sep 2026 Company Update Thyrocare Technologies Ltd - 539871 - Announcement under Regulation 30 (LODR)-Newspaper Publication
28 Sep 2026 AGM/EGM Thyrocare Technologies Ltd - 539871 - Shareholder Meeting / Postal Ballot-Notice of Postal Ballot
28 Sep 2026 Shareholders meeting Thyrocare Technologies Limited has informed the Exchange regarding Notice of Postal Ballot
24 Sep 2026 Options to purchase securities Thyrocare Technologies Limited has informed the Exchange about Grant of Options under Thyrocare Employee Stock Option Scheme.
24 Sep 2026 Trading Window Thyrocare Technologies Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015
21 Sep 2026 Sale or disposal Thyrocare Technologies Limited has informed about the sale of the entire shareholding held by the Company in Nueclear Healthcare Limited (a material wholly owned subsidiary), subject to the approval of the shareholders of the Company.
21 Sep 2026 Acquisition Please find attached intimation regarding Acquisition of Compulsorily Convertible Preference Shares of Trovera Healthcare Private Limited as part-consideration for the sale of Nueclear Healthcare Limited (a material wholly owned subsidiary).
21 Sep 2026 Updates Thyrocare Technologies Limited has informed the Exchange regarding 'Outcome of the Board Meeting held on Monday, September 21, 2026'.
21 Sep 2026 Company Update Thyrocare Technologies Ltd - 539871 - Sale Of The Entire Shareholding Held By The Company In Nueclear Healthcare Limited (A Material Wholly Owned Subsidiary), Subject To The Approval Of The Shareholders Of The Company

All announcements →

SWOT

Tradinity's own rule-based read of the real ratios elsewhere on this page -- not a copy of any third party's, and never a forward-looking prediction.

Strengths

  • High Return on Equity (27.8%)
  • Strong net profit margin (22.2%)
  • Low financial leverage (Debt/Equity 0.00)
  • Comfortable interest coverage (61.1x)
  • Strong revenue growth YoY (26.1%)

Weaknesses

Data unavailable.

Opportunities

Data unavailable.

Threats

  • Down 53.5% over the past year

Board of directors and corporate information →

F&O

View F&O, Options & Backtest →

Data unavailable (no single-stock futures or options activity on record for this company).

Frequently asked questions about Thyrocare Technologies Limited

Where is the share price?

The price at the top of this page is the last traded price from exchange data; during market hours it refreshes on its own. The Chart & Technicals section has the full price history.

Where are the financial results?

The Financials page has quarterly and annual results, ratios, cash flow and the balance sheet, on a standalone or consolidated basis.

Who owns the company?

The Ownership section shows the latest shareholding pattern from exchange filings, with promoter, FII, DII and public holdings by quarter.

Does Tradinity give buy or sell advice?

No. The scores and checklist on this page are rule-based summaries of published figures, not recommendations. Tradinity is not a registered investment adviser.